Globe Life (NYSE:GL) Issues FY25 Earnings Guidance

Globe Life (NYSE:GL) updated its FY25 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $13.20-13.90 for the period, compared to the consensus estimate of $13.25. Globe Life also updated its FY 2024 guidance to 12.200-12.400 EPS.

Analyst Ratings Changes

GL has been the subject of several recent analyst reports. Raymond James lifted their price objective on shares of Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a research note on Tuesday, October 15th. Truist Financial lifted their price target on shares of Globe Life from $80.00 to $90.00 and gave the stock a “hold” rating in a research note on Friday, July 26th. Piper Sandler increased their price objective on shares of Globe Life from $106.00 to $118.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Keefe, Bruyette & Woods reissued an “outperform” rating and issued a $118.00 price objective (up previously from $110.00) on shares of Globe Life in a research note on Wednesday, July 31st. Finally, Evercore ISI upped their target price on Globe Life from $83.00 to $86.00 and gave the company an “in-line” rating in a research note on Wednesday, June 26th. Five research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $117.40.

Globe Life Stock Down 0.2 %

Shares of GL traded down $0.21 during midday trading on Wednesday, reaching $110.86. 640,291 shares of the stock were exchanged, compared to its average volume of 1,601,265. The company has a market capitalization of $9.98 billion, a P/E ratio of 10.60 and a beta of 0.81. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.31. Globe Life has a 52 week low of $38.95 and a 52 week high of $132.00. The company’s 50 day moving average is $104.60 and its two-hundred day moving average is $90.63.

Globe Life (NYSE:GL) last posted its earnings results on Wednesday, July 24th. The company reported $2.97 EPS for the quarter, beating analysts’ consensus estimates of $2.90 by $0.07. Globe Life had a net margin of 18.47% and a return on equity of 21.93%. The business had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.45 billion. During the same quarter last year, the firm posted $2.61 EPS. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. On average, sell-side analysts anticipate that Globe Life will post 11.93 earnings per share for the current year.

Globe Life Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Friday, October 4th will be issued a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a yield of 0.87%. The ex-dividend date of this dividend is Friday, October 4th. Globe Life’s payout ratio is 9.17%.

Insiders Place Their Bets

In related news, Director Mary E. Thigpen purchased 3,000 shares of the business’s stock in a transaction dated Friday, July 26th. The shares were acquired at an average cost of $90.20 per share, for a total transaction of $270,600.00. Following the acquisition, the director now owns 15,605 shares of the company’s stock, valued at $1,407,571. The trade was a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.51% of the stock is owned by company insiders.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.